newsfilter
← Latest News
PR Newswire·

Tryp Therapeutics to Present at the H.C. Wainwright Psychedelics Conference on December 6, 2021

SAN DIEGO, Dec. 3, 2021 /PRNewswire/ -- Tryp Therapeutics (CSE:TRYP) (OTCQB:TRYPF) ("Tryp or the "Company"), a pharmaceutical company focused on developing psilocybin-based compounds for diseases with unmet medical needs, announced today that it will pre